Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
The trouble with TIGITs: How 'overenthusiasm' led to Big Pharma's risky $6B gamble
Boston Children's Hospital
Research
'Active' vaccine adjuvant boosts COVID, flu antibodies in mice
Researchers think they may have found one of the most potent adjuvants so far: an immunomodulating small molecule called PVP-037.
Helen Floersh
Jul 9, 2024 4:00am
Sickle cell gene therapy process may cause cancerous mutations
Nov 20, 2023 9:10am
Chronic pain pathway linked to lung cancer
Sep 1, 2022 9:15am
ElevateBio, Boston Children's Hospital collab on new CAR-T biz
Aug 4, 2022 11:00am
Study of dogs and cats sheds light on key immune pathways
Aug 6, 2021 2:00pm
Attacking pancreatic cancer with an I-O drug conjugate
Nov 9, 2020 8:31am
